Biofilm studies yield targets against cystic fibrosis

Drug Discovery Today

Volumn 7, Issue 23, 2002, Pages 1147-1148

  Flores, Graciela ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CHLORIDE CHANNEL; MEMBRANE PROTEIN; PROTEIN OPRF; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC THERAPY; BIOFILM; CYSTIC FIBROSIS; DRUG MECHANISM; DRUG RESEARCH; DRUG TARGETING; GENE MUTATION; GENETIC CODE; HUMAN; LUNG INFECTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; SHORT SURVEY;

BIOFILMS; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEMS; HUMANS; PSEUDOMONAS INFECTIONS;

EID: 0036894165     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02524-2     Document Type: Short Survey

References (4)

1. Yoon S.S., et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell. 3:2002;593-603.
2. Worlitzsch D., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:2002;317-325.
3. Erickson D.L., et al. Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis. Infect. Immun. 70:2002;1783-1790.
4. Price B.M., et al. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 33:2002;89-99.